<DOC>
<DOCNO>EP-0643968</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Molded pharmaceutical form for oral delivery of acetylsalicyclic acid or its salts and method to prepare it.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K920	A61K920	A61K3160	A61K3160	A61K4712	A61K4712	A61P2500	A61P2504	A61P2900	A61P2900	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	A61K	A61K	A61P	A61P	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K9	A61K9	A61K31	A61K31	A61K47	A61K47	A61P25	A61P25	A61P29	A61P29	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The pharmaceutical form, which is stable, comprises a mixture of a compound a) chosen from acetylsalicylic acid and its pharmaceutically acceptable salts and a citrate b) chosen from neutral magnesium citrate and acid magnesium citrate, this mixture being finely distributed in a porous matrix based on a pharmaceutically acceptable binding agent.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
LAFON LABOR
</APPLICANT-NAME>
<APPLICANT-NAME>
LABORATOIRE L. LAFON
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
LEYDER JOELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
NGUYEN THANH TAM
</INVENTOR-NAME>
<INVENTOR-NAME>
LEYDER, JOELLE
</INVENTOR-NAME>
<INVENTOR-NAME>
NGUYEN, THANH TAM
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
